NATASHA LOFTIN: Open Payments
NPI 1740551613 · LEXINGTON, TN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$182 in 9 payments from 7 companies in 2025. Trend: 2023 $415 · 2024 $122 · 2025 $182
Food & beverage: $182
| Company | Payments | Amount |
|---|---|---|
| GlaxoSmithKline, LLC. | 3 | $55 |
| Antares Pharma, Inc. | 1 | $24 |
| Xeris Pharmaceuticals, Inc. | 1 | $24 |
| ABBVIE INC. | 1 | $21 |
| Novo Nordisk Inc | 1 | $20 |
| Boston Scientific Corporation | 1 | $19 |
| Verona Pharma, Inc. | 1 | $19 |
Products named: TRELEGY ELLIPTA, XYOSTED, GVOKE HYPOPEN, QULIPTA, Rybelsus, General - Therapies, Ohtuvayre.
Industry payments across TN — which companies pay providers there.
